Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
Introduction: Malignant hyperthermia is an autosomal dominant pharmacogenetic disorder, characterized by hypermetabolic crisis triggered by halogenated anesthetics and/or succinylcholine. The standard method for diagnosing malignant hyperthermia susceptibility is the in vitro muscle contracture test...
Main Authors: | Helga Cristina Almeida da Silva, Elton Shinji Onari, Isac de Castro, Marcelo Vaz Perez, Alexandre Hortensi, José Luiz Gomes do Amaral |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Brazilian Journal of Anesthesiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0104001419300533 |
Similar Items
-
Patient suspected susceptibility to malignant hyperthermia: impact of the disease
by: Gislene Rodrigues, et al.
Published: (2023-03-01) -
How would a completely homogeneous malignant hyperthermia susceptible sample be?
by: Pamela Vieira de Andrade, et al.
Published: (2024-01-01) -
Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil
by: Helga Cristina Almeida da Silva, et al.
Published: (2019-03-01) -
An Association between OXPHOS-Related Gene Expression and Malignant Hyperthermia Susceptibility in Human Skeletal Muscle Biopsies
by: Leon Chang, et al.
Published: (2024-03-01) -
Malignant Hyperthermia in Brazil: Analysis of Hotline Activity in 2009
by: Helga Cristina Almeida da Silva, et al.
Published: (2013-01-01)